2.24

0.44% -0.010

After Hours: 2.24

Cyclerion Therapeutics Inc (CYCN)

Overview News Price History Financials Discussions Forecast Stock Split

Cyclerion Therapeutics Inc stock is traded at $2.24, with a volume of 26,723. It is down -0.44% in the last 24 hours and down -3.86% over the past month. Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Previous Close:

$2.25

Open:

$2.3

24h Volume:

26,723

Relative Volume:

0.08

Market Cap:

$7.48M

Revenue:

$556.00K

Net Income/Loss:

$-5.28M

P/E Ratio:

-1.0467

EPS:

-2.14

Net Cash Flow:

$-6.23M

1W Performance:

-3.86%

1M Performance:

-3.86%

6M Performance:

-18.55%

1Y Performance:

-6.67%

1-Day Range:

$2.2103

$2.3089

1-Week Range:

$2.2103

$2.4599

52-Week Range:

$1.27

$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name

Cyclerion Therapeutics Inc

Sector

Healthcare (1135)

Industry

Biotechnology (636)

Phone

617-621-7722

Address

301 BINNEY STREET, CAMBRIDGE, MA

Employee

Twitter

@Cyclerion

Next Earnings Date

2024-12-15

Latest SEC Filings

CYCN's Discussions on Twitter

Compare CYCN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CYCN Cyclerion Therapeutics Inc	2.24	7.21M	556.00K	-5.28M	-6.23M	-2.14
VRTX Vertex Pharmaceuticals Inc	416.81	104.76B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.67	63.06B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	578.05	60.32B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	843.66	51.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	165.76	34.49B	398.11M	-1.03B	-868.57M	-5.7032

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-21	Initiated	Truist	Buy
Sep-24-21	Initiated	Cantor Fitzgerald	Overweight
Jun-03-19	Initiated	Credit Suisse	Neutral

Cyclerion Therapeutics Inc Stock (CYCN) Latest News

11:57 AM

Will Cyclerion Therapeutics Inc. stock recover faster than peersWeekly Investment Summary & Reliable Entry Point Alerts - Trung tâm Dự báo KTTV quốc gia

11:57 AM

12:11 PM

Published on: 2025-10-16 23:11:04 - newser.com

12:11 PM

Oct 16, 2025

Pattern recognition hints at Cyclerion Therapeutics Inc. upside2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com

Oct 16, 2025

Oct 15, 2025

Using R and stats models for Cyclerion Therapeutics Inc. forecastingShare Buyback & Capital Protection Trading Alerts - newser.com

Oct 15, 2025

Tick level data insight on Cyclerion Therapeutics Inc. volatilityWeekly Investment Recap & Stock Timing and Entry Methods - newser.com

Oct 15, 2025

Detecting support and resistance levels for Cyclerion Therapeutics Inc.2025 Trade Ideas & High Win Rate Trade Tips - newser.com

Oct 15, 2025

Can momentum traders help lift Cyclerion Therapeutics Inc.July 2025 Retail & Verified Chart Pattern Trade Signals - newser.com

Oct 15, 2025

Published on: 2025-10-15 03:45:24 - newser.com

Oct 15, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 3% Higher – Here’s Why - Defense World

Oct 15, 2025

Oct 14, 2025

Should you hold or exit Cyclerion Therapeutics Inc. now2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Oct 14, 2025

How to use a screener to detect Cyclerion Therapeutics Inc. breakoutsJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com

Oct 14, 2025

Oct 13, 2025